Showing results (1471-1480 of 7,557) with videos related to

Sort By:
Pageof 756
Molecular Pharmaceutics|April 18, 2019
Quantifying Carcinoembryonic Antigen-like Cell Adhesion Molecule-Targeted Liposome Delivery Using Imaging Flow CytometryJason Kuhn, Asya Smirnov, Alison K Criss, et al.
Molecular Pharmaceutics|April 18, 2019
Small Molecular Theranostic Assemblies Functionalized by Doxorubicin-Hyaluronic Acid-Methotrexate Prodrug for Multiple Tumor Targeting and Imaging-Guided Combined Chemo-Photothermal TherapyYilin Chen, Qing Chen, Qixin Zhu, et al.
Molecular Pharmaceutics|October 3, 2018
An NIR-Guided Aggregative and Self-Immolative Nanosystem for Efficient Cancer Targeting and Combination Anticancer TherapyQiang Zheng, Yun He, Qing Tang, et al.
Molecular Pharmaceutics|August 18, 2018
Susceptibility of Antibody CDR Residues to Chemical Modifications Can Be Revealed Prior to Antibody Humanization and Aid in the Lead Selection ProcessAnkai Xu, Hok Seon Kim, Samarkand Estee, et al.
Molecular Pharmaceutics|June 12, 2018
Development of [18F]AlF-NOTA-NT as PET Agents of Neurotensin Receptor-1 Positive Pancreatic CancerMengzhe Wang, He Zhang, Hui Wang, et al.
Molecular Pharmaceutics|December 17, 2009
Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticlesVarun Kumar, Sam Y Hong, Anna E Maciag, et al.
Molecular Pharmaceutics|December 25, 2009
Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healingYan Li, Ping I Lee
Molecular Pharmaceutics|December 6, 2005
Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epitheliumFilippos Kesisoglou, Joel R Chamberlain, Phyllissa Schmiedlin-Ren, et al.
Molecular Pharmaceutics|May 15, 2018
Metabolism of an Oxime-Linked Antibody Drug Conjugate, AGS62P1, and Characterization of Its Identified MetaboliteJosh T Snyder, Maria-Christina Malinao, Julien Dugal-Tessier, et al.
Molecular Pharmaceutics|May 16, 2018
Ionic-Liquid-Based Paclitaxel Preparation: A New Potential Formulation for Cancer TreatmentMd Raihan Chowdhury, Rahman Md Moshikur, Rie Wakabayashi, et al.
Pageof 756